J.W. Cole Advisors Inc. Buys Shares of 1,885 Addus HomeCare Co. (NASDAQ:ADUS)

J.W. Cole Advisors Inc. purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 1,885 shares of the company’s stock, valued at approximately $251,000.

Other large investors also recently modified their holdings of the company. UMB Bank n.a. grew its holdings in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the period. Quest Partners LLC bought a new stake in shares of Addus HomeCare in the second quarter valued at $31,000. Innealta Capital LLC purchased a new position in shares of Addus HomeCare during the 2nd quarter valued at $44,000. EntryPoint Capital LLC bought a new position in shares of Addus HomeCare during the 1st quarter worth $44,000. Finally, Sandia Investment Management LP purchased a new stake in Addus HomeCare in the 2nd quarter worth about $58,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Down 1.0 %

NASDAQ:ADUS opened at $124.42 on Friday. The stock has a market cap of $2.25 billion, a P/E ratio of 30.87, a PEG ratio of 2.33 and a beta of 1.04. The business’s 50-day moving average price is $130.32 and its two-hundred day moving average price is $119.87. Addus HomeCare Co. has a twelve month low of $78.35 and a twelve month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. During the same period last year, the firm posted $0.94 earnings per share. Addus HomeCare’s quarterly revenue was up 10.4% on a year-over-year basis. On average, equities research analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have commented on ADUS. TD Cowen upped their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Oppenheimer raised their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Royal Bank of Canada reiterated an “outperform” rating and issued a $141.00 price objective on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Stephens restated an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. Finally, Macquarie reiterated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Friday, October 11th. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.38.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,917 shares of company stock worth $3,050,082. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.